Initially consisting of 1800 antibodies, the library is expected to grow by several thousand per year with the goal of producing at least one antibody to all 22,000 non-redundant human proteins by 2015. Through this partnership, Sigma-Aldrich is granted exclusive distribution rights in the US and all regions outside of Europe, with co-exclusive distribution rights in Europe.
Marianne Hansson, co-founder and CEO of Atlas Antibodies, said: “This partnership will enable Atlas Antibodies to reach all of the proteomics and cell biology researchers who will benefit from the unprecedented specification of the Prestige Antibodies.”